Smith & Nephew PLC
SN.: XLON (GBR)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|%$P | LOCK|sd?> | LOCK|#Q^tMH |
Smith & Nephew Earnings: Weak Orthopedics Growth Drags Down Quarterly Results
Smith & Nephew reported third-quarter underlying revenue growth of 3%, with outsize contribution from sports medicine joint repair that rose 11% year over year.
